NEWARK, DELAWARE | March 12, 2026 — The global Beta-Glucanase Market is entering a period of sustained growth, repositioning itself as a cornerstone of the functional ingredients industry. Driven by a global shift toward preventative healthcare and "clean-label" solutions, the market—valued at USD 495.0 million in 2026—is projected to reach USD 912.0 million by 2036, expanding at a steady 6.3% CAGR, according to the latest strategic outlook by Future Market Insights (FMI).

The expansion, representing an absolute dollar growth of USD 417.0 million, is fueled by a surge in demand from dietary supplement manufacturers and functional food formulators. While the market benefits from strong tailwinds in the immune and cardiovascular health sectors, growth is moderated by the premium costs of standardized preparations and the rigorous clinical substantiation required for regulatory health claims.

Get Access to the Full Report Sample: Explore detailed forecasts, segment insights, and competitive analysis

The Evolution of Ingredients: Science-Backed Wellness

The primary catalyst for this decade-long expansion is the rising consumer awareness of immune health and cardiovascular risk management. Beta-Glucanase, a bioactive ingredient derived from yeast, cereal grains, and fungi, has gained significant traction due to EFSA and FDA-recognized claims regarding cholesterol reduction and heart health.

"The central procurement challenge today is not product availability, but supplier qualification and traceability," says Nandini Roy Choudhury, Principal Consultant at FMI. "Buyers consolidating volumes around yeast face concentration risks. Executives who delay formalizing supplier diversification strategies will find their cost structures exposed as regulatory enforcement cycles intensify."

Segment Insights: Yeast and Solubility Lead the Charge

The market is characterized by a clear preference for established, highly bioavailable formats that integrate seamlessly into existing manufacturing lines.

• Yeast-Derived Source: This segment remains the undisputed leader, commanding a 47.3% market share in 2026. Its dominance is anchored by cost-effective production methods and high yield potential via fermentation.
• Soluble Functionality: Accounting for 61.8% of the market, soluble beta-glucanase is preferred for its ease of incorporation into beverages and liquid supplements, offering superior bioavailability.
• Health & Dietary Supplements: As the largest application segment (29.3% share), this sector is driven by the post-pandemic prioritization of immune resilience and gut health.

Regional Performance: Asia-Pacific Accelerates

While the United States and Europe remain high-value hubs with established regulatory frameworks, the highest velocity of growth is concentrated in Asia, supported by massive investment in enzyme biotechnology.

Competitive Landscape: Purity and Compliance

The market features a mix of global life sciences giants and specialized enzyme producers focusing on high-purity extraction. Key players include:

• Cargill Inc. (USA)
• Kerry Group Plc (Ireland)
• Koninklijke DSM N.V. (Netherlands)
• Tate & Lyle Plc (UK)
• Angel Yeast Co Ltd (China)
• Ohly GmbH (Germany)

Strategic Implications for Industry Stakeholders

• Verify Certification: Suppliers must establish clear traceability pathways to qualify for procurement tenders from large-scale food and pharma buyers.
• Target High-Growth Hubs: Investment should prioritize capacity expansion in China and India to capture incremental demand before supply concentration shifts pricing power.
• Reformulate for Regulation: Product teams must align formulations with evolving EU, US FDA, and Asia-Pacific thresholds to maintain global market access.

Why FMI: https://www.futuremarketinsights.com/why-fmi

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals.

An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities.

For Press & Corporate Inquiries

Rahul Singh

AVP - Marketing and Growth Strategy

Future Market Insights, Inc.

+91 8600020075

For Sales - sales@futuremarketinsights.com

For Media - Rahul.singh@futuremarketinsights.com

For web - https://www.futuremarketinsights.com/